Patients with autoimmune rheumatic diseases have long been known to be at increased risk of developing non-Hodgkin lymphoma (NHL). In this Review, the authors evaluate the new data that has emerged since 2006 regarding the clinical factors that contribute to the increased risk of the different B-cell NHL subtypes in patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome.
- Catarina Dias
- David A. Isenberg
